Author: admin

“Vascular Access Device Market”

(Albany, USA) In 2022, the global Vascular Access Device market was valued at USD 4.59 billion. It is expected to grow at a CAGR of 6.64% from 2023 to 2028, reaching USD 6.75 billion by 2028. The increasing prevalence of chronic diseases, including cancer, kidney failure, and heart disease, is a key driver for the demand for these devices. Factors such as the rise in chemotherapy, lifestyle diseases, and their increasing occurrence in pediatric patients are also contributing to market growth. Some of the key players in the Global Vascular Access Device Market include Cook Medical Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Inc., Smiths Group PLC, Nipro Medical Corporation, and others.

DelveInsight’s “Vascular Access Device Market Insight, Competitive Landscape, and Market Forecast 2028” research report provides the current and forecasted Vascular Access Device market size, share, and trends analysis for the next five years. Moreover, it highlights the ongoing innovations in the segment, major market drivers & barriers, key competitors, and emerging devices in the domain.

Vascular Access Device Market: Overview

A Vascular Access Device (VAD) is a medical device that allows healthcare professionals to access the bloodstream for various purposes, such as administration of fluids, medications, blood products, or monitoring purposes. VADs are crucial in situations where prolonged or frequent access to the vascular system is needed. There are various types of Vascular Access Devices, and their selection depends on the specific clinical requirements of the patient.

Benefits of Vascular Access Devices:

• Improved Patient Comfort: VADs can reduce the need for repeated needle sticks, making treatment more comfortable for patients.
• Long-Term Access: VADs provide a means for prolonged access to the vascular system, reducing the need for frequent needle insertions.
• Facilitates Complex Treatments: VADs allow for the administration of medications and treatments that may be too irritating for peripheral veins.
• Convenience for Healthcare Providers: Healthcare professionals can administer treatments and draw blood more easily with VADs, especially in cases where frequent access is required.

Applications of Vascular Access Devices:

• Chemotherapy: Implanted ports and PICCs are commonly used for the administration of chemotherapy drugs.
• Long-Term Antibiotic Therapy: Central venous catheters may be used for patients requiring prolonged antibiotic treatments.
• Parenteral Nutrition: VADs can be utilized for the delivery of nutrients directly into the bloodstream in patients who cannot consume food orally.
• Hemodialysis: Hemodialysis catheters are essential for patients with kidney failure who require regular dialysis.
• Blood Transfusions: VADs can facilitate the administration of blood products.

Request for sample page @ https://www.delveinsight.com/sample-request/vascular-access-device-market

To provide a better understanding of the market dynamics, DelveInsight’s “Vascular Access Device Market” report provides a detailed assessment by device type (Central Vascular Access Device [Peripherally Inserted Central Catheter (PICC), Non-Tunneled Catheters, and others], and Peripheral Vascular Access Device [Peripheral Catheter, Midline Catheter (short) Devices, and others]), and Route of Insertion (Intravenous and Subcutaneous).

In the Vascular Access Device market’s device type segment, peripherally inserted central catheters (PICC) within the central Vascular Access Device category are expected to dominate. This is due to the associated advantages of PICCs, allowing long-term access for fluid injection or blood withdrawal. PICCs facilitate access to large central veins near the heart for effective medication administration, causing less pain and reducing the need for frequent needle sticks. They also minimize the risk of irritation to smaller arm veins. Another advantage is the potential for multiple lumens in PICCs, enabling the simultaneous administration of various medications, such as fluids and chemotherapy.

Vascular Access Device Market Analysis

The escalating incidence of chronic and infectious diseases worldwide is poised to drive a significant surge in the Vascular Access Device market. This growth can be attributed to the heightened demand for effective medical interventions and therapies necessitated by the rising global burden of chronic diseases like cancer, kidney failure, heart disease, and others. Vascular Access Devices play a crucial role in providing sustained access to the bloodstream and facilitating the administration of medications, fluids, and other essential treatments. As healthcare systems grapple with the challenges posed by increasing disease prevalence, the demand for these devices is expected to rise, underscoring their pivotal role in contemporary medical care.

Furthermore, market growth may be propelled by additional factors, including the increasing frequency of chemotherapy treatments, the prevalence of lifestyle-related diseases, and a notable rise in these conditions among pediatric patients. The escalating need for Vascular Access Devices in diverse medical scenarios, especially in oncology for chemotherapy administration, reflects a growing demand for advanced healthcare solutions. The expanding incidence of lifestyle diseases further accentuates the relevance of Vascular Access Devices in managing chronic conditions. Additionally, the rise in pediatric patients requiring these devices underscores the market’s adaptability to evolving healthcare needs across different demographics.

Nevertheless, the expansion of the overall vascular devices market may encounter constraints due to complications and elevated costs linked to various Vascular Access Devices. The intricate nature of these devices, coupled with potential complications such as infections, thrombosis, and mechanical issues poses challenges for both patients and healthcare providers. Additionally, the financial burden associated with the procurement, maintenance, and management of these devices can impede market growth. For a wider acceptance and greater user trust,  there is a growing emphasis on research and development aimed at enhancing device efficacy, reducing complications, and exploring cost-effective alternatives to ensure sustained growth in the vascular devices market.

Interested to know more about the ongoing developments in the market? Visit to get an in-depth insight @ Vascular Access Device Types and Emerging Products                                             

Global Vascular Access Device Market Assessment and Forecast

North America is expected to dominate the overall Vascular Access Device market during the forecast period. The region’s prominence is driven by an increasing demand for cutting-edge technologies in Vascular Access Devices, a rising imperative to address patients afflicted with chronic and infectious diseases, and a surge in product development initiatives. According to the American Cancer Society, approximately 82,290 new cases of bladder cancer are projected for 2023 in the United States, with around 62,420 cases in men and 19,870 in women. Additionally, based on CDC data from 2020, cystic fibrosis (CF), a genetic disorder impacting breathing and digestion, affects an average of 35,000 individuals annually in the United States. The demand for Vascular Access Devices is intricately linked to the increasing prevalence of conditions such as bladder cancer, cystic fibrosis (CF), and various chronic diseases, emphasizing their pivotal role in delivering essential treatments and medications.

Furthermore, the growth of the Vascular Access Devices market will be bolstered by an increase in hospital admissions, attributed to a heightened prevalence of infectious diseases necessitating intravenous medication administration. The surge in patient admissions underscores the critical role of Vascular Access Devices in facilitating efficient and sustained delivery of medications, fluids, and other essential treatments. As healthcare facilities grapple with the challenges posed by infectious diseases, the demand for reliable and effective vascular access solutions is poised to escalate, further propelling market expansion.

The robust healthcare infrastructure, coupled with a proactive approach toward adopting advanced medical solutions, positions North America at the forefront of the global Vascular Access Device landscape. This strategic advantage is expected to contribute significantly to the region’s sustained leadership in the market. Moreover, continuous regulatory approvals and the increasing focus of key manufacturers on launching new products in the market will also boost the market growth in the North American region in the coming years.

Interested in knowing how the market will grow by 2028? Click to get a snapshot @ Vascular Access Device Market Trends and Developments

Key Developments and Breakthroughs in the Vascular Access Device Market

Over the years, the Vascular Access Device market has evolved significantly, owing to the active participation of the global MedTech companies and technological advancements in the domain. Similarly, several clinical, commercial, and regulatory developments have also been registered in the domain. Some of the major advancements in the Vascular Access Device market in recent years include –

• On November 07, 2023, Alucent Biomedical announced that the U.S. Food & Drug Administration (FDA) granted an Investigational Device Exemption (IDE) for a U.S. clinical study of its AlucentNVS technology for promoting the maturation of arteriovenous fistulas (AVF) in patients requiring hemodialysis. AlucentNVS combines an intravascular device with a photochemical process to link structural proteins in the wall of a blood vessel to control vascular remodeling. The intervention is designed to promote patency of the vessel’s lumen and establish sustained improvement of blood flow.
• In August 2021, PuraCath Medical™ announced that it has received 510(k) clearance for its FireFly™ Needleless Connector from the US Food and Drug Administration (FDA). The Firefly™ Needleless Connector is a sterile single-patient-use connector for needleless access to the IV line and IV catheter during IV therapy and can be used for direct injection, intermittent infusion, continuous infusion, or aspiration. This regulatory determination by the FDA gives PuraCath clearance to market the FireFly™ needleless connector in the US.
• In July 2021, Artio Medical, Inc. announced it has completed enrollment in its first-in-human study evaluating the company’s Amplifi™ Vein Dilation System. The Amplifi System is designed to stimulate arm vein enlargement in hemodialysis patients using rapid, non-pulsatile venous blood flow. A novel vein dilation system aims to improve vascular access for hemodialysis patients.
• In March 2020, the Biowy PICC-S kit received 510(k) clearance from the US FDA.

Learn more about major clinical and commercial development in the market @ Vascular Access Device Market – Clinical and Commercial Development Activities

Key Companies in the Global Vascular Access Device Market

Companies play a pivotal role in the Global Vascular Access Device Market, driving innovation, research, and product development to meet the ever-evolving demands of healthcare. On a global scale, prominent players in the Vascular Access Device market encompass esteemed MedTech giants such as Cook Medical Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Inc., Smiths Group PLC, Nipro Medical Corporation, and other. These companies are at the forefront of advancing technology and medical solutions, continually striving to enhance the safety and efficacy of Vascular Access Devices. 

Scope of the Vascular Access Device Market Report:

• Study Period – 2020-2028
• Geography Covered – North America, Europe, Asia-Pacific, and Rest of the World
• Vascular Access Device Market Assessment 

• By Device Type – Central Vascular Access Device (Peripherally Inserted Central Catheter (PICC), Non-Tunneled Catheters, and Others), and Peripheral Vascular Access Device (Peripheral Catheter, Midline Catheter (short) Devices), and others
• By Route of Insertion – Intravenous and Subcutaneous
• End-User – Hospitals, Ambulatory Surgical Centres, and others
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s Views

Table of Content

1. Vascular Access Device Market Report Introduction

2. Executive Summary

3. Regulatory and Patent Analysis

4. Vascular Access Device Market Key Factors Analysis

5. Vascular Access Device Porter’s Five Forces Analysis

6. COVID-19 Impact Analysis on the Vascular Access Device Market

7. Vascular Access Device Market Layout

8. Vascular Access Device Global Company Share Analysis – Key 3–5 Companies

9. Vascular Access Device Product Profiles and Key Companies

10. Vascular Access Device Project Approach

11. Vascular Access Device KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/primary-research-services

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Vascular Access Device Market Expected to Expand by 6.64% CAGR from 2023 to 2028, Featuring Leading Players Such as Amecath Medical, AngioDynamics, B Braun Melsungen, Becton, Dickinson, and Company

“Embolic Protection Devices Market”

The global market for Embolic Protection Devices, valued at USD 1.37 billion in 2022, is projected to grow at a 7.5% CAGR from 2023 to 2028, reaching USD 2.11 billion by 2028. The demand for these devices is being driven by the rising incidence of cardiovascular diseases such as stroke and stenosis. Factors contributing to this growth include increased adoption of advanced technologies, a growing preference for minimally invasive treatments, higher obesity rates, and an increase in product launches and approvals. Some of the key players such as Boston Scientific Corporation, Abbott, Medtronic, Cordis, Contego Medical, inc., Integer Holdings Corporation, InspireMD Inc., Emboline, Inc., Keystone Heart Ltd., and others are actively wronging in the Global Embolic Protection Devices Market. 

DelveInsight’s “Embolic Protection Devices Market Insight, Competitive Landscape, and Market Forecast 2028” research report provides the current and forecasted Embolic Protection Devices market size, share, and trends analysis for the next five years. Moreover, it highlights the ongoing innovations in the segment, major market drivers & barriers, key competitors, and emerging devices in the domain.

Embolic Protection Devices Market: Overview

Embolic Protection Devices, often used in medical procedures, are specialized tools designed to safeguard against the risk of embolization, which occurs when debris or fragments, such as blood clots, plaque, or other foreign materials, break loose and travel through the bloodstream. These devices serve a crucial role in a variety of medical applications, most notably during interventional procedures like angioplasty or stent placement in blood vessels, particularly in the coronary and carotid arteries. They are instrumental in preventing these embolic materials from reaching vital organs or causing blockages, which can lead to severe complications like strokes or heart attacks.

The benefits of Embolic Protection Devices are multifaceted. They significantly reduce the risk of embolization during invasive medical procedures, enhancing patient safety and outcomes. By trapping or diverting embolic materials away from critical arteries, these devices help minimize the chances of post-procedural complications and the need for additional interventions. Moreover, they enable healthcare professionals to perform minimally invasive techniques, resulting in quicker recovery times, reduced hospital stays, and less postoperative discomfort for patients. Additionally, Embolic Protection Devices contribute to the overall efficacy and success of interventional procedures, allowing for more precise treatment and better long-term results.

In terms of applications, Embolic Protection Devices find their primary use in a range of cardiovascular and vascular interventions. These include coronary artery interventions, such as angioplasty and stent placement, as well as carotid artery procedures for stroke prevention. They are also utilized in various other vascular territories to mitigate the risk of embolization in conditions like peripheral artery disease, where blockages can occur in the extremities. The use of these devices is expanding into other medical fields, such as neurology and oncology, where embolization poses a threat during procedures like brain aneurysm treatment and certain cancer therapies. In summary, Embolic Protection Devices are vital tools with a wide array of applications, safeguarding patients and improving the efficacy of interventional medical procedures.

To provide a better understanding of the market dynamics, DelveInsight’s “Embolic Protection Devices Market” report provides a detailed assessment by product (distal occlusion devices, distal filters, and proximal occlusion devices), application (cardiovascular disease, neurovascular diseases, and others), end-user (hospitals & clinics, ambulatory surgical centers, and others), and geography (North America, Europe, Asia-pacific, and rest of the world).

Within the product segment of the Embolic Protection Devices market, distal filters are poised to secure a substantial share of revenue in the upcoming years. This can be attributed to their user-friendly design and easy maintenance, making them a preferred choice among healthcare practitioners and patients alike. Distal filter Embolic Protection Devices have been witnessing a growing demand, primarily driven by the escalating prevalence of cardiovascular diseases, including heart attacks and strokes. The surge in cardiovascular cases necessitates procedures like coronary artery bypass surgery, subsequently fueling the need for Embolic Protection Devices.

The advantages inherent to distal filter devices over other types play a pivotal role in this increasing demand. Their ability to effectively intercept embolic materials and protect vital organs during procedures not only enhances patient safety but also contributes to the overall success of interventions. As a result, the uptake of distal filter Embolic Protection Devices is expected to surge, bolstering the growth of the overall Embolic Protection Devices market throughout the forecast period. This trend underscores the pivotal role played by distal filters in ensuring the safety and efficacy of cardiovascular and vascular interventions, ultimately benefiting both patients and healthcare professionals.

Request for sample report @ https://www.delveinsight.com/sample-request/embolic-protection-devices-market

Embolic Protection Devices Market Analysis

The Embolic Protection Devices market is witnessing a positive growth in product demand owing to various factors, one of the key factors is the increase in the prevalence of coronary heart disease, carotid artery disease, and others. Coronary heart disease occurs when the walls of arteries become furred up with fatty deposits, which is called atherosclerosis, so the increasing cases of arteriosclerosis can ultimately increase the risk of coronary heart disease which requires coronary artery bypass surgery for removing extra fat from vessels. While removing this fat, Embolic Protection Devices are used to capture atherothrombotic debris.

A recent study by the Heart Research Institute found that individuals in reasonably good health over the age of 40 have a roughly 50% likelihood of developing significant atherosclerosis. This increased prevalence of atherosclerosis may lead to coronary heart disease, potentially necessitating coronary artery bypass surgery, during which Embolic Protection Devices are utilized to capture atherothrombotic debris. Consequently, the rising incidence of atherosclerosis is likely to drive greater demand for Embolic Protection Devices in the market.

Furthermore, the escalating global obesity epidemic is a significant health concern linked to atherosclerosis. According to the World Health Organization (2021), obesity has reached epidemic proportions, resulting in at least 2.8 million annual fatalities worldwide due to overweight and obesity-related complications. Individuals carrying excess weight are at heightened risk for atherosclerosis, which can lead to conditions like angina or stroke, often requiring atherectomy procedures. During atherectomy, medical professionals employ Embolic Protection Devices to capture luminal debris, preventing embolization. Consequently, the growing prevalence of obesity, with its associated need for interventions targeting fat accumulation, is expected to boost the demand for Embolic Protection Devices, ultimately contributing to the overall market growth in this sector.

In addition to the previously discussed factors, the growth of the Embolic Protection Devices market will also be bolstered by strategic initiatives like new product introductions, regulatory approvals, and intensified research endeavors. The continuous introduction of innovative devices and the green light from regulatory bodies signify the industry’s commitment to enhancing patient care and safety. Furthermore, ongoing research efforts aim to uncover more effective solutions and improve existing technologies, further elevating the standards of Embolic Protection Devices. These proactive measures collectively pave the way for robust market expansion in the coming years, ensuring that patients and healthcare professionals benefit from state-of-the-art advancements in this crucial medical field.

In addition to the previously discussed factors, the growth of the Embolic Protection Devices market will also be bolstered by strategic initiatives like new product introductions, regulatory approvals, and intensified research endeavors. The continuous introduction of innovative devices and the green light from regulatory bodies signify the industry’s commitment to enhancing patient care and safety. Furthermore, ongoing research efforts aim to uncover more effective solutions and improve existing technologies, further elevating the standards of Embolic Protection Devices. These proactive measures collectively pave the way for robust market expansion in the coming years, ensuring that patients and healthcare professionals benefit from state-of-the-art advancements in this crucial medical field.

In addition to the previously discussed factors, the growth of the Embolic Protection Devices market will also be bolstered by strategic initiatives like new product introductions, regulatory approvals, and intensified research endeavors. The continuous introduction of innovative devices and the green light from regulatory bodies signify the industry’s commitment to enhancing patient care and safety. Furthermore, ongoing research efforts aim to uncover more effective solutions and improve existing technologies, further elevating the standards of Embolic Protection Devices. These proactive measures collectively pave the way for robust market expansion in the coming years, ensuring that patients benefit from state-of-the-art advancements in this crucial medical field.

However, the availability of alternative devices and others may restrict the Embolic Protection Devices market growth.

Interested to know more about the ongoing developments in the market? Visit to get an in-depth insight @ Embolic Protection Devices Types and Emerging Products

Global Embolic Protection Devices Market Assessment and Forecast 

In the landscape of the Embolic Protection Devices market, North America is poised to dominate with the largest share in the coming years. Several critical factors contribute to this region’s prominence, with a robust growth trajectory driven by the increasing incidence of coronary heart disease and carotid artery disease. 

As per data from the Centers for Disease Control and Prevention (CDC) in 2020, coronary heart disease emerged as the prevalent cardiovascular condition in the United States, contributing to a significant toll with 382,820 fatalities. Additionally, the CDC’s 2022 statistics reveal a startling reality in the country, where approximately 805,000 individuals experience heart attacks on an annual basis. Among this cohort, 605,000 individuals undergo their initial heart attack, while the remaining 200,000 have already grappled with the ordeal in the past. These alarming figures underscore the substantial burden placed on the U.S. healthcare system and emphasize the pressing need for effective medical interventions, such as Embolic Protection Devices, to mitigate the impact of heart-related ailments and enhance patient outcomes.

Furthermore, the escalating rates of obesity among the population and other related factors have propelled the demand for Embolic Protection Devices in North America. This region is expected to continue its positive growth momentum, underscoring its pivotal role in addressing the pressing healthcare needs associated with cardiovascular conditions and related risk factors. The thriving market in North America not only reflects the significance of these factors but also emphasizes the region’s commitment to advancing medical interventions for improved patient outcomes.

Moreover, the considerable disposable income, well-developed healthcare infrastructure, increasing regulatory approvals for innovative products, and a heightened awareness of the benefits of minimally invasive surgical procedures are expected to contribute significantly to the growth of this region’s Embolic Protection Devices market. With these favorable conditions in place, North America stands as a prime hub for advancements in medical technologies, enabling patients to access cutting-edge treatments and fostering a conducive environment for market expansion. The region’s emphasis on healthcare innovation, coupled with its economic prosperity and well-informed patient base, underscores its role as a driving force in propelling the market forward.

Therefore, the aforementioned factors would provide a growth environment for the North American region in the embolic protection device market.

Interested in knowing how the market will grow by 2028? Click to get a snapshot @

Embolic Protection Devices Market Trends and Developments

Key Developments and Breakthroughs in the Embolic Protection Devices Market

Over the years, the Embolic Protection Devices market has evolved significantly, owing to the active participation of the global MedTech companies and technological advancements in the domain. Similarly, several clinical, commercial, and regulatory developments have also been registered in the domain. Some of the major advancements in the Embolic Protection Devices market in recent years include –

• On Oct. 27, 2023, Sirtex Medical (“Sirtex”) announced the commercial availability of the LAVA® Liquid Embolic System, the first and only liquid embolic approved for the treatment of peripheral vascular hemorrhage. LAVA® provides volume and viscosity options that optimize the flexibility needed to treat patients with controlled target vessel occlusion. The product’s 2mL and 6mL options are optimized for the peripheral vasculature, and its viscosity options allow for the distal embolization of small vessels that may be inaccessible via other embolics.
• In October 2020, Keystone Heart Ltd., a Venus Medtech Company, announced that the TriGUARD 3 Cerebral Embolic Protection (CEP) Device received European CE certification. This device is developed to reduce the risk of stroke by trapping embolic particles away from the brain.
• In February 2020, the FDA approved a temporary catheter by Boston Scientific Corporation for embolic protection during Transcatheter intracardiac procedures.

Key Companies in the Global Embolic Protection Devices Market

Companies play a pivotal role in the Global Embolic Protection Devices Market, driving innovation, research, and product development to meet the ever-evolving demands of healthcare. On a global scale, prominent players in the Embolic Protection Devices market encompass esteemed MedTech giants such as Boston Scientific Corporation, Abbott, Medtronic, Cordis, Contego Medical, inc., Integer Holdings Corporation, InspireMD Inc, Emboline, Inc., Keystone Heart Ltd., and others. These companies are at the forefront of advancing technology and medical solutions, continually striving to enhance the safety and efficacy of Embolic Protection Devices. 

Companies are investing heavily in research and development, aiming to create more sophisticated and efficient devices that reduce the risk of embolization during medical procedures. Furthermore, companies are responsible for obtaining regulatory approvals, ensuring product quality, and establishing distribution networks, all of which are essential to bring these life-saving devices to healthcare professionals and patients. Their dedication to improving patient outcomes and addressing the pressing healthcare needs associated with cardiovascular and vascular conditions makes them instrumental in shaping the trajectory of the Embolic Protection Devices market.

Learn how new players’ entries will transform the market dynamics in the coming years @ Embolic Protection Devices’s Competitive Landscape

Scope of the Embolic Protection Devices Market Report:

• Study Period – 2020-2028
• Geography Covered – North America, Europe, Asia-Pacific, and Rest of the World
• Embolic Protection Devices Market Assessment
• By Product – Distal Occlusion Devices, Distal Filters, and Proximal Occlusion Devices
• By Application – Cardiovascular Disease, Neurovascular Diseases, and Others
• End-User – Hospitals & Clinics, Ambulatory Surgical Centers, and Others
• Geography – North America, Europe, Asia-Pacific, and Rest of the World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s Views

Table of Content

1. Report Introduction

2. Executive Summary

3. Regulatory and Patent Analysis

4. Embolic Protection Devices Market Key Factors Analysis

5. Embolic Protection Devices Porter’s Five Forces Analysis

6. COVID-19 Impact Analysis on the Embolic Protection Devices Market

7. Embolic Protection Devices Market Layout

8. Embolic Protection Devices Global Company Share Analysis – Key 3–5 Companies

9. Embolic Protection Devices Product Profiles and Key Companies

10. Project Approach

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Global Embolic Protection Devices Market is projected to Expand Significantly at a 7.5% CAGR from 2023 to 2028 | Companies – Sirtex Medical (LAVA Liquid Embolic System), Abbott, Medtronic, InspireMD